Identification and characterization of two novel primate-specific histone H3 variants, H3.X and H3.Y by Wiedemann, Sonja M. et al.
JCB: Article
The Rockefeller University Press    $30.00
J. Cell Biol. Vol. 190 No. 5  777–791
www.jcb.org/cgi/doi/10.1083/jcb.201002043 JCB 777
Correspondence to Sandra B. Hake: Sandra.hake@med.uni-muenchen.de
Abbreviation used in this paper: 3D-SIM, 3D structured illumination microscopy; 
DG, dentate gyrus; DIC, differential interference contrast; GFAP, glial fibrillary 
acidic protein; GO, gene ontology; IF, immunofluorescence; IP, immunoprecipi-
tation; LC-MS/MS, liquid chromatography tandem mass spectrometry; NeuN, 
neuronal nuclei; PTM, posttranslational modification; qPCR, quantitative PCR; 
RP-HPLC, reversed-phase HPLC; SO, starvation and overgrowth.
Introduction
Chromatin, the storage and regulatory form of genetic informa-
tion in eukaryotes, consists of nucleosomes that are composed 
of DNA and octamers of the core histones H2A, H2B, H3, and 
H4 (van Holde, 1988). To allow changes in chromatin structure, 
which are necessary to promote different biological functions, 
several interconnected mechanisms have evolved (for review 
see Bönisch et al., 2008). Among others, these include the slid-
ing or eviction of nucleosomes by ATP-dependent chromatin 
remodeling machines (for review see Clapier and Cairns, 2009), 
posttranslational modifications (PTMs) of histone proteins 
(Strahl and Allis, 2000), and the exchange of canonical histones 
with specialized histone variants (for reviews see Pusarla and 
Bhargava, 2005; Bernstein and Hake, 2006). Histone variants 
differ in sequence and expression timing from their canonical 
counterparts and are enriched in chromatin of specific func-
tional states, ranging from DNA repair and centromere determi-
nation to the regulation of gene expression. In mammals, variants 
of the H3, H2A, and H2B families of histones have been identi-
fied  whose  incorporation  results  in  nucleosomes  with  novel 
functional and structural properties (Suto et al., 2000; Abbott   
et al., 2001; Angelov et al., 2003; Bao et al., 2004; Gautier   
et al., 2004).
To date, five different H3 variants have been found in 
mammals: H3.1, H3.2, H3.3, H3.1t (tH3), and CENP-A. The 
centromeric H3 variant CENP-A causes changes to the nucleo-
somal structure (Black et al., 2004) and is crucial for proper 
chromosome segregation (for review see Allshire and Karpen, 
2008). tH3 is a testis-specific histone variant with a putative 
N
ucleosomal incorporation of specialized histone 
variants is an important mechanism to gener-
ate different functional chromatin states. Here, 
we  describe  the  identification  and  characterization  of 
two novel primate-specific histone H3 variants, H3.X and 
H3.Y. Their messenger RNAs are found in certain human 
cell lines, in addition to several normal and malignant   
human tissues. In keeping with their primate specificity, 
H3.X and H3.Y are detected in different brain regions. 
Transgenic H3.X and H3.Y proteins are stably incorporated 
into chromatin in a similar fashion to the known H3 vari-
ants. Importantly, we demonstrate biochemically and by 
mass spectrometry that endogenous H3.Y protein exists   
in vivo, and that stress stimuli, such as starvation and cellular 
density, increase the abundance of H3.Y-expressing cells. 
Global transcriptome analysis revealed that knockdown 
of H3.Y affects cell growth and leads to changes in the 
expression of many genes involved in cell cycle control. 
Thus, H3.Y is a novel histone variant involved in the regu-
lation of cellular responses to outside stimuli.
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depending on the search program used (“polyadq” or PolyA_SVM 
program), H3.X and H3.Y 3 genomic sequences of human and 
primate origins were predicted to include a conserved poly-A 
site (Tabaska and Zhang, 1999; Cheng et al., 2006). Alignment 
of human and primate H3.X and H3.Y coding sequences with 
respective human H3 variant sequences revealed a higher simi-
larity to H3.3 than to H3.2 and H3.1 (Fig. S1 C).
H3.X and H3.Y genes are predicted to encode proteins of 
146 and 135 amino acids, respectively (Fig. 1 A). Both putative 
variant proteins are highly similar to each other, with differences 
of only four amino acids in their overlapping region (89.7% iden-
tity). H3.X has an unusual long C-terminal tail with no sequence 
homology to other proteins (Fig. 1 A). H3.X and H3.Y display 
interesting changes in amino acids that are known to be posttrans-
lationally modified in H3.1, H3.2, and H3.3: serine 10 and 28, 
which are phosphorylated during mitosis (Hendzel et al., 1997) 
and immediate early gene induction (Clayton and Mahadevan, 
2003), are altered to alanine and arginine, respectively. Regions 
surrounding lysine 14, usually acetylated and found in actively 
transcribed genes (Yan and Boyd, 2006), and lysine 79, methylated 
in transcriptionally active regions (Im et al., 2003) and upon DNA 
damage (Huyen et al., 2004), are completely altered (Fig. 1 A).   
In several instances, single amino acid changes between novel 
and known H3 variants have occurred, thereby generating or   
eliminating potential PTM sites. The region surrounding aa 87–90 
is important for the chaperone-dependent chromatin incorpora-
tion of histone variants (Ahmad and Henikoff, 2002b). CAF-1 
deposits H3.1, whereas HIRA catalyzes the incorporation of H3.3 
(Tagami et al., 2004). The residues of H3.X and H3.Y in this 
region are identical to H3.3 (Fig. 1 A), leading to the hypothesis 
that these putative novel variants might be incorporated by HIRA 
in a replication-independent manner.
To  assess  whether  both  genes  are  expressed  in  human 
cells, we analyzed their RNA expression levels in a variety of 
cell lines by quantitative PCR (qPCR; Fig. 1 B). Because the 
nucleotide  sequences  of  H3.X  and  H3.Y  are  almost  identical 
(Fig. S1 A), we generated one primer set detecting both H3.X 
and H3.Y mRNAs and one additional primer set that hybridizes   
with H3.X-specific 3 sequences. We demonstrate that both H3.X  
and H3.Y genes are transcribed at low levels in the human osteo-
sarcoma  cell  line  U2OS,  with  H3.Y  in  higher  amounts  than   
H3.X, but 16-fold lower than the histone variant CENP-A   
(Fig. S1 D). Minimal expression of H3.Y was detected in human 
HEK293 cells, whereas no expression was seen in HeLa as well 
as in mouse cells (negative control; Fig. 1 B). These data suggest 
that H3.X and H3.Y genes are transcribed in some human cell 
lines, albeit at low total levels.
Our  observation  that  H3.X  and  H3.Y  mRNAs  are  ex-
pressed in U2OS cells inspired us to examine RNAs from differ-
ent human tissues by qPCR. Of particular interest were human 
malignant tissues, as U2OS cells are derived from a moderately 
differentiated sarcoma of the tibia. We also chose to investigate 
several regions of the human brain and testis due to the primate-
specific appearance of H3.X and H3.Y. Interestingly, we found 
that some bone, breast, lung, and ovary tumors express low but 
significant levels of H3.X/Y mRNA (Fig. 1 C). Analyzing RNA 
from human brain areas and testis, H3.X/Y expression was   
function in chromatin reorganization during spermatogenesis 
(Witt et al., 1996). H3.1 and H3.2 sequences are distinguishable 
by just one amino acid. Although expression of both is replica-
tion dependent (Ahmad and Henikoff, 2002a), they differ in 
their cell type expression levels as well as their enrichment of 
PTMs (Hake et al., 2006). Furthermore, H3.1 has been impli-
cated in DNA damage response pathways (Polo et al., 2006) 
and is deposited into chromatin by the chaperone complex 
CAF-1 (Tagami et al., 2004), whereas H3.3 is expressed and in-
corporated into chromatin in a replication-independent manner 
by HIRA (Tagami et al., 2004). The latter variant is highly deco-
rated  with  modifications  associated  with  gene  transcription 
(McKittrick et al., 2004; Hake et al., 2006) and is thought to be 
involved in activating gene expression (Ahmad and Henikoff, 
2002a) and epigenetic reprogramming (for review see Santenard 
and Torres-Padilla, 2009).
Here, we describe the identification of two novel primate-
specific histone H3 variants (H3.X and H3.Y) that are transcribed 
at low levels in some human cell lines and in normal and ma-
lignant tissues. Their amino acid sequences are highly simi-
lar  to  each  other,  but  differ  in  several  functionally  important 
residues from other H3 variants, e.g., S10 and S28. Transgenic 
H3.X and H3.Y proteins localize to the nucleus and are sta-
bly incorporated into chromatin. We demonstrate that endog-
enous H3.Y protein is highly expressed in some osteosarcoma 
cells. Interestingly, the number of cells expressing H3.Y is in-
creased by particular stress stimuli. Knockdown of H3.Y leads to   
diminished growth and changes in the expression of many genes 
controlling cell cycle progression. The observed presence of 
primate-specific  histone  H3  variants  in  specific  human  brain   
areas opens up fascinating questions about their roles in human 
cell determination and differentiation.
Results
Identification of novel H3 variant genes
Using  the  nucleotide  sequence  of  human  histone  H3.1f  
(HIST1H3I;  available  from  GenBank/EMBL/DDBJ  under   
accession no. NM_003533), we searched the public database 
(National Center for Biotechnology Information) and identi-
fied two highly similar genes initially annotated as pseudogenes 
(Fig. S1 A). These two intron-free genes, which we named   
H3.X (GenBank/EMBL/DDBJ accession no. LOC340096) and 
H3.Y (GenBank/EMBL/DDBJ accession no. LOC391769), 
are located on human chromosome 5 (5p15.1). Further data-
base searches revealed the existence of similar genes in pri-
mate genomes (Pan troglodytes H3.X, GenBank/EMBL/DDBJ   
accession no. LOC471464; and H3.Y, GenBank/EMBL/DDBJ 
accession no. LOC471473; Macaca mulatta H3.X, GenBank/ 
EMBL/DDBJ accession no. LOC718189; and H3.Y, GenBank/ 
EMBL/DDBJ accession no. LOC718280; Fig. S1 B). Searches 
for these genes in other mammalian genomes yielded no posi-
tive  hits,  which  suggests  that  they  evolved  in  evolutionarily 
younger terms and might constitute primate-specific histones. 
Both human genes contain a sequence matching the translation 
initiation start site consensus (underline) for vertebrates (GCC-
GCCACCAUGGCG; Kozak, 1991; Nakagawa et al., 2008), and 779 Characterization of novel histone H3.Y • Wiedemann et al.
were transfected into HeLa cells and, in the case of HA-tagged 
variants, at least two independent stable cell populations were 
selected. In both HA-H3.X– and HA-H3.Y–expressing HeLa 
cells, nuclear HA signals in interphase and staining of con-
densed chromatin in mitotic cells were observed by immuno-
fluorescence (IF) microscopy (Fig. 2 A). Signals were also present 
on metaphase chromosome spreads (Fig. 2 B), which suggests 
that these novel tagged H3 variants are stably incorporated into 
chromatin and constitute core nucleosomal components. Next, 
we asked if the amino acid differences between H3.X, H3.Y, 
and other H3 variants have any impact on nucleosome structure. 
Thus, we calculated in silico models of H3.X and H3.Y pro-
tein structures, using the published structure of Xenopus laevis 
H3.2 as a template (Davey et al., 2002). With these, we compu-
tationally assembled a nucleosome containing H3.X or H3.Y. 
Our data show only few differences to the published structure of 
H3.2, with an exception being the unusual C terminus of H3.X 
observed in all samples except for the thalamus. In contrast to all 
other tissues tested, H3.X mRNA could also be detected in the 
brain and testis samples (Fig. 1 C).
In conclusion, mRNAs of the novel primate-specific H3 
variants H3.X and H3.Y are not only present in human cell 
lines, but are also detected in primary cells from different   
human organs.
Tagged H3.X and H3.Y proteins are similar 
to canonical histone H3 in their nuclear 
localization, nucleosome structure,  
and exchange mobility kinetics
The  detection  of  H3.X  and  H3.Y  mRNA  in  human  cells 
prompted us to investigate their protein products. We ampli-
fied their coding sequences from U2OS cDNA and cloned them   
under  the  constitutively  active  cytomegalovirus  promoter  in 
frame with an N-terminal HA or GFP tag. These constructs 
Figure 1.  Sequence and mRNA expression analysis of novel H3 variants H3.X and H3.Y. (A) Amino acid sequence alignment of human histone variants 
H3.1, H3.2, and H3.3 with novel variants H3.X and H3.Y. Alignments were made with ClustalW Alignment (MacVector 10.0.2). Identical amino acids 
are highlighted in dark gray, similar amino acids are highlighted in light gray, and changes are set apart on a white background. The black bar indicates 
the peptide sequence used for antibody generation. Black stars mark known PTM sites in H3.1, H3.2, and H3.3. The gray star indicates an H3.3-specific 
modification site. Amino acid numbers are indicated on top. (B) qPCR analysis with cDNA from different human cell lines shows expression of H3.Y and to 
a lesser extent H3.X mRNA in U2OS cells. Primer pair H3.X+Y (dark gray) specifically recognizes H3.X and H3.Y nucleotide sequences, whereas another 
primer pair is H3.X specific (H3.X, light gray). NIH3T3 mouse cDNA was used as a negative control. Data were normalized to HPRT1 and HMBS expres-
sion levels. Controls generated without reverse transcription were used to assess amplification threshold. Error bars represent SEM of two independent 
biological experiments. (C) Expression of H3.X and H3.Y mRNA in normal and malignant human tissues. Commercially available total RNA from human 
tissues was analyzed for H3.X+Y and H3.X expression in qPCR experiments and compared with results obtained with controls generated without reverse 
transcription. The number of samples that were positive for H3.X+Y and H3.X expression (+) are indicated in brackets.JCB • VOLUME 190 • NUMBER 5 • 2010   780
that, unlike H3.1 and H3.3 (Tagami et al., 2004), these tagged 
novel variants form heterotypic nucleosomes with regard to their 
variant composition. To assess the incorporation stability of these   
novel variants, we performed FRAP experiments with GFP-tagged 
H3 variants transiently transfected into HeLa Kyoto cells, which 
were chosen because of their slow cell motility. These experi-
ments demonstrate similar dissociation kinetics for the novel GFP-
tagged H3 variants compared with GFP-H3.1 and -H3.3 (Fig. 3, 
D and E; and Fig. S2, B–D). GFP fluorescence recovery rates 
of all H3 variants were very slow (>8 h; Fig. S2, B–D) in com-
parison to GFP alone (a few seconds; Fig. 3, D and E), which is 
indicative of stable chromatin-bound immobile populations.
In summary, tagged H3.X and H3.Y protein containing 
nucleosomes are similar in their predicted structure and indis-
tinguishable from nucleosomes containing H3.1 or H3.3 in their 
FRAP mobility and chromatin-association behavior.
(Fig. 3 A). Surprisingly, this extended C-terminal tail of H3.X is 
proposed to fold into an additional -helix that fits into the free 
space of the nucleosomal core structure (Fig. 3 B, left).
Because our in silico models proposed no dramatic changes 
in nucleosomal structure for H3.Y, but some differences for 
H3.X, we asked whether H3.X and/or H3.Y are incorporated 
into nucleosomes in a cellular context and whether they exhibit 
a similar stability compared with nucleosomes containing H3.1, 
H3.2, or H3.3. Immunoprecipitation (IP) of mononucleosomes 
generated from HeLa cells expressing HA-tagged H3 variants   
using an -HA antibody confirmed the incorporation of HA-H3.X 
and -H3.Y into chromatin (Figs. 3 C and S2 A). Additionally, sil-
ver staining and immunoblots revealed that HA-H3.X and -H3.Y 
are present in nucleosomes containing all four core histones.   
Interestingly, HA-H3.X and -H3.Y containing mononucleosomes 
also contained endogenous H3 (Fig. 3 C, right), which suggests 
Figure 2.  Subcellular localization of HA-H3.X and -H3.Y histone proteins. (A) Confocal imaging of stably transfected HeLa cells shows nuclear localiza-
tion of HA-H3.1, -H3.X, and -H3.Y proteins. Cells were costained with TO-PRO3 (DNA, gray, left), -HA (green, middle left), and -H3S10ph (red, middle 
right). Overlay is shown on the right (merge). The left side shows interphase and the right side shows mitotic cells, as indicated by -H3S10ph staining. 
(B) Metaphase spreads of mitotically arrested HeLa cells transfected with empty vector and HA-H3.1, -H3.X, and -H3.Y. Deconvolved wide-field images of 
chromosomes costained with DAPI (DNA, blue, left) and -HA (green, middle). Sections containing one chromosome (red arrowhead) stained with -HA 
are depicted on the far right. All HA-H3 variants are incorporated into chromosomes. Bars: (A) 5 µm; (B) 10 µm.781 Characterization of novel histone H3.Y • Wiedemann et al.
Figure 3.  Structure and stability of H3.X- and H3.Y-containing nucleosomes. (A) In silico homology model of H3.X (purple, left) and H3.Y (light blue, right) 
protein structures in overlay with the crystal structure of H3.2 (dark blue). (B) Crystal structure of nucleosome with H3.2 exchanged by in silico homology 
models of H3.X (purple, left) and H3.Y (light blue, right), respectively. (C) IP of mononucleosomes generated from HeLa cells transfected with empty vector, 
HA-H3.1, -H3.X, and -H3.Y shows incorporation of novel H3 variants into nucleosomes. Bioanalyzer evaluation of purified DNA after IP of MNase-treated 
chromatin (unbound and bound material) shows digestion of chromatin to mononucleosomes and their successful precipitation (left; see also Fig. S2 A for 
DNA size and quality). Silver stain of 15% SDS-PAGE with -HA IPs of mononucleosomes revealed successful binding of HA-tagged H3 variants (asterisks) 
and pull-down of core histones (top, right). Immunoblot of immunoprecipitates with -HA (red) and -H3 C-terminal (green) antibodies visualized by the 
Odyssey infrared imaging system (bottom, right). Notice that endogenous H3 is coimmunoprecipitated with all H3 variants analyzed. (D) FRAP experiments 
to evaluate nucleosomal stability of novel H3 variants using spinning disk confocal microscopy. HeLa Kyoto cells were transiently transfected with GFP, 
GFP-H3.1, -H3.3, -H3.X, and -H3.Y constructs. A small nuclear area was photobleached (box) and the recovery of the fluorescent signal was monitored 
over 1 min and up to 8 h (see Fig. S2, B–D, for long-term FRAP). Depicted is a short-term FRAP series (selected time points are shown) of GFP-tagged 
H3 variants compared with GFP alone. Bar, 5 µm. (E) Quantification of short-term FRAP experiment. Mean curves of 10–20 individual cells are shown. 
Standard deviations were very small (in the range of ± 0.02) and were omitted for clarity (for details see Fig. S2 D). All GFP-H3 variants show almost no 
recovery within the first 60 s after bleaching, which indicates that all expressed fusion protein was stably incorporated into nucleosomes. In contrast, GFP 
alone recovers to almost 100% within 5 s.JCB • VOLUME 190 • NUMBER 5 • 2010   782
to an increase in the percentage of cells with nuclear -H3.X/Y 
staining (unpublished data). To evaluate if starvation alone, or 
in combination with high cell density, caused this increase in   
-H3.X/Y–positive  cell  numbers,  we  either  subjected  U2OS 
cells to starvation or cultivated them under SO conditions.   
In three independent biological experiments, we quantified (1) 
the percentage of -H3.X/Y nuclear-stained cells by IF micros-
copy, (2) H3.X/Y mRNA levels by qPCR, and (3) H3.X/Y pro-
tein levels by immunoblot analyses. Interestingly, we observed 
an approximately sixfold increase in the number of -H3.X/Y 
nuclear-stained cells under SO conditions, whereas starvation 
alone only showed a minor effect (threefold increase; Fig. 5 A). 
In addition, we could reproducibly show, by qPCR (Fig. 5 B) 
and immunoblots (Fig. 5 C), that both H3.X/Y RNA and protein 
are up-regulated upon SO treatment compared with normally 
growing  cells.  We  observed  a  stronger  increase  of  H3.X/Y- 
than H3.X-specific amplicons (Fig. 5 B), which suggests that 
H3.Y mRNA expression is specifically affected by this partic-
ular stress condition. This was further validated by a “primer-
walk” experiment with several different primer pairs that span 
the  entire  H3.X  or  H3.Y  coding  sequence  (Fig.  S3,  A–C).   
Additionally, the induced protein band observed in immunoblots 
corresponds to a protein of the size of recombinant H3.Y but not 
H3.X (Fig. 5 C). To assess the question of which factors in the   
growth medium cause the observed effect, we also analyzed   
-H3.X/Y nuclear stained cells after serum starvation and amino 
acid depletion. However, we did not observe any significant dif-
ference caused by both treatments (unpublished data).
These data show a direct correlation between -H3.X/Y 
antibody staining and the increased mRNA and protein levels due 
to SO treatment. Furthermore, they suggest that H3.Y expression, 
in particular, is positively affected by these growth conditions.
Endogenous H3.Y protein is expressed 
after SO treatment
Our  experiments  indicate  that  H3.Y  expression  is  mostly,   
if not exclusively, induced in U2OS cells under SO conditions. 
To confirm this observation, we purified histones from HEK293, 
NIH3T3, and SO-treated and normally grown U2OS cells by 
reversed-phase HPLC (RP-HPLC; Fig. S4 A). Fractions sur-
rounding and including peaks corresponding to H3.2 and H3.3 
(peak I) and H3.1 (peak II; Fig. 6 A) were analyzed by immuno-
blots with -H3.X/Y. Specific signals were observed in frac-
tions eluting at the beginning of peak I (region A bands) and 
between peak I and II (region B bands; Fig. 6 B). Interestingly, 
region A bands correspond to proteins of the molecular weight 
of histone H3, the predicted size of H3.Y. As expected for H3.Y, 
these bands are faintly visible in normally grown U2OS cells 
and strongly enhanced in those cultured under SO conditions. 
In contrast, no such bands are present in NIH3T3 and HEK293 
cells. Region B bands are indicative of proteins of 35 kD and 
are clearly visible without any change in intensity in all human   
cell lines, but not in mouse NIH3T3 cells. Fractions correspond-
ing to region A and B bands from SO treated cells from two 
independent experiments and normally grown U2OS cells were 
analyzed by liquid chromatography tandem mass spectrometry 
(LC-MS/MS). For region B fractions, no conclusive information 
Endogenous H3.X/Y proteins are expressed 
in U2OS cells and localize to the nucleus
To characterize endogenous H3.X/Y proteins, we generated 
a  monoclonal  antibody  against  these  variants  (-H3.X/Y;  see   
Fig. 1 A, black line, for peptide sequence). -H3.X/Y specific-
ity was tested in diverse experiments using HeLa cells stably   
expressing HA-tagged H3 variants. Immunoblot analysis of acid-
extracted histones from these cell lines revealed that -H3.X/Y 
specifically recognizes HA-H3.X and -H3.Y, but not HA-H3.1, 
-H3.2, or -H3.3 (Fig. 4 A). In IF microscopy analyses with this 
antibody,  HA-H3.X  and  -H3.Y  showed  an  exclusive  nuclear 
staining (Fig. S2 E), which could be confirmed to be specific for 
H3.X/Y by peptide competition assays (Fig. S2 F).
To analyze the expression of endogenous H3.X and H3.Y 
proteins,  we  isolated  total  histones  from  different  cell  lines. 
As a negative control, we used mouse NIH3T3 cells and, as a   
positive  control,  HeLa  cells  expressing  HA-H3.X.  Immuno-
blotting of these histones with -H3.X/Y showed a faint band in 
the lane containing U2OS histones corresponding to the size of 
H3, which would be expected for H3.Y (Fig. 4 B). These data 
are  consistent  with  our  previous  finding  that  U2OS  cells  ex-
press mostly H3.Y mRNA (Fig. 1 B). Next, we addressed the 
subcellular  localization  of  endogenous  H3.X  and/or  H3.Y  in 
U2OS  cells  by  confocal  IF  microscopy.  -H3.X/Y  shows  a 
faint and dotted staining associated with the nuclear rim in all 
cells, which might be due to cross-reactivity with nuclear pores. 
Interestingly, we also noticed that few U2OS cells showed a 
strong nuclear -H3.X/Y staining, colocalizing with DNA   
(Fig. 4 C, arrowhead), which was not observed in cell lines of 
mouse or rat origin (Fig. 4 D). Some few mitotic U2OS cells, as   
well as metaphase chromosomes, also stained positive with   
-H3.X/Y (Fig. 4, E and F, respectively), which suggested that the 
observed -H3.X/Y signal marks a stable chromatin component. To   
shed light on the subnuclear localization of endogenous H3.X/Y   
in U2OS cells, we performed super-resolution (i.e., below the dif-
fraction limit of conventional optical microscopy) imaging with 
3D structured illumination microscopy (3D-SIM; Gustafsson et al., 
2008; Schermelleh et al., 2008). As depicted in Fig. 4 G, H3.X/Y 
is predominantly located outside of DAPI-dense regions, arguing 
for an association of endogenous H3.X/Y with less condensed, 
more euchromatic regions.
Nutritional- and growth-associated  
stress stimuli increase the number of 
H3.X/Y-expressing cells
Because only 0.1% of U2OS cells showed a general nuclear 
staining with -H3.X/Y, we wondered what cellular features 
distinguished these from other cells. We hypothesized that spe-
cific  stress  stimuli  induce  the  nuclear  -H3.X/Y  staining.   
To test this assumption, we induced DNA damage with different 
treatments (UV, etoposide, and hydroxyurea) but were unable 
to detect a significant increase in the percentage of cells positive 
for -H3.X/Y staining (unpublished data). Next, we addressed 
the question of whether cell growth and nutrition could have 
an  impact  on  H3.X/Y  expression.  Interestingly,  induction  of 
starvation and overgrowth (SO) in U2OS cells for 8 d, but not 
overgrowth alone (for details, see Materials and methods), led 783 Characterization of novel histone H3.Y • Wiedemann et al.
with increasing amounts of DTT (Fig. S4 B). In contrast to 
H3.1, H3.2, and H3.3, we did not observe a change in molecular 
weight for region B bands, which suggests that these particular 
proteins are not dimers of H3.X and/or H3.Y.
Interestingly, in region A fractions, we were able to iden-
tify two peptides specific for H3.X/Y (aa 53–63 and 73–83), in 
about the protein identity could be obtained. Only one single 
peptide corresponding to H3.X/Y (aa 53–63) could be observed 
in B-type fractions, rendering the analysis of these particular 
fractions inconclusive. To eliminate the possibility that region 
B bands constitute a dimeric aggregate caused by formation of 
disulfide bonds between cysteines, we treated these fractions 
Figure 4.  Detection of endogenous H3.X and/or H3.Y proteins. (A) A monoclonal antibody against H3.X/Y (-H3.X/Y) was generated by immunizing rats 
with an N-terminal peptide specific for H3.X and H3.Y (aa 9–20, see also black line in Fig. 1 A). Immunoblots of acid-extracted histones from HeLa cells 
stably transfected with empty vector, or vectors containing HA-H3.1, -H3.2, -H3.3, -H3.X, and -H3.Y. Histones from two independently selected HeLa cell 
populations expressing HA-H3.X and -H3.Y were used (#1 and #2). (A, top) Staining of the membrane with -H3.X/Y antibody shows only signals in lanes 
loaded with histones from HeLa cells expressing HA-H3.X and -H3.Y, but not in lanes containing general HA-H3 variants, which demonstrates the specificity 
of the antibody toward the novel variants in immunoblotting. (A, bottom) Equal loading was controlled by -HA staining. Note that all bands run slower, as 
expected, because of the HA tag. HA-H3.X runs even slower than all other HA-H3 variants because of its extended C-terminal tail. (B) Immunoblot analysis 
of acid-extracted histones from different cell lines with -H3.X/Y antibody. (B, top) Histones from HeLa cells expressing HA-H3.X served as positive control, 
and histones from mouse NIH3T3 cells served as a negative control. A faint signal in the lane containing U2OS histones can be seen. (B, bottom) The identi-
cal membrane was stained with Ponceau S solution before antibody incubation to control for protein loading. Dotted lines indicate that intervening lanes 
have been spliced out. (C) Confocal IF analysis of U2OS cells costained with -H3.X/Y (green), -H3S10ph (mitosis-specific, red), and TO-PRO3 (DNA, 
gray). Confocal midsections are shown. (D) Confocal IF analysis of mouse (left) and rat (right) cells costained with -H3.X/Y (green), -H3S10ph (red), and 
TO-PRO3 (DNA, gray) as negative controls. (E) Confocal IF analysis of mitotic U2OS cells costained with -H3.X/Y (green), -H3S10ph (mitosis-specific, 
red), and TO-PRO3 (DNA, gray). (F) Costaining of metaphase chromosomes derived from mitotically arrested U2OS cells with -H3.X/Y (green) and DAPI 
(DNA, blue). The boxed inlet shows enlargement of one chromosome. (G) Super-resolution 3D-SIM imaging of U2OS cells costained with -H3.X/Y (green) 
and DAPI (DNA, blue). Depicted are cells expressing low (left) and high (right) levels of H3.X/Y. Bars: (C–F) 10 µm; (G, left) 5 µm; (G, right) 0.5 µm.JCB • VOLUME 190 • NUMBER 5 • 2010   784
addition to the expected general H3 peptides (Figs. 6 C and S4, 
C and D). Furthermore, one peptide exclusively present in H3.Y 
but not H3.X (aa 18–28) was repeatedly detected (Figs. 6 C and 
S4 E), leading to a combined sequence coverage of 33% for 
H3.Y. Interestingly, in conjunction with unmodified H3.Y pep-
tide, we were also able to identify acetylation of lysines 18, 23, 
and 27 (Fig. S4, F and G). These PTMs are also present in the 
known H3 variants, indicating that H3.Y was a likely part of a 
nucleosome and present in chromatin fibers.
In summary, these data show that posttranslationally mod-
ified H3.Y protein is expressed in vivo, and that under stress- 
inducing conditions, more H3.Y-expressing cells are present.
Knockdown of H3.Y affects expression of 
cell cycle–related genes and cell growth
Because we could clearly demonstrate the presence of endoge-
nous H3.Y protein in human cells, we wondered about the biologi-
cal consequences of its expression. We hypothesized that the natural 
substitution of amino acids S10, K14, S28, and K79 in H3.Y and its 
preferential exclusion from DAPI-dense regions (Fig. 4 G) might 
result in gene expression changes at the sites of chromatin incor-
poration. Therefore, we used global expression arrays to examine 
a potential impact on the regulation of gene expression by H3.Y. 
We used RNAi to significantly reduce H3.Y and H3.X+H3.Y 
mRNAs and proteins. siRNAs directed against H3.Y, H3.X+Y, 
and luciferase, as control, were designed and their specificity 
verified by transfection of HeLa cells expressing HA-tagged H3.X 
and H3.Y, followed by IF analysis (Fig. 7 A). Next, we sought to 
quantitatively compare global RNA expression profiles after RNAi 
in SO-treated U2OS cells using Affymetrix Human Gene 1.0 ST 
Arrays (performed twice with independent transfections on differ-
ent days). We verified the proper knockdown of H3.Y (and H3.X) 
mRNAs by qPCR (Fig. 7 B) and observed a modest but signifi-
cant deregulation of genes when compared with control luciferase 
RNAi in global microarray analyses (Fig. 7, C and D; and Tables 
S1 and S2). Cells transfected with H3.Y-specific siRNAs showed   
293 genes up-regulated and 974 genes down-regulated. Cells 
treated with H3.X+Y-specific siRNAs had 1,106 genes up-regulated 
and 1,249 genes down-regulated (local false discovery rate 
cutoff of 0.2). To eliminate off-target and sole H3.X-specific effects 
and to focus only on H3.Y-specific responses, Venn diagrams of   
overlapping deregulated genes between H3.Y- and H3.X+Y-
  specific siRNA changes were used. They revealed up-regulation of 
73 and down-regulation of 229 shared genes (Fig. 7 C). Gene ontol-
ogy (GO) enrichment analysis of the deregulated genes classified   
shared down-regulated genes to mainly belong to cell cycle-
  controlling pathways, but also chromatin organization and meta-
bolic pathways, whereas only few GO groups of shared up-regulated 
genes could be determined (Tables S1 and S2). Because the ma-
jority of genes affected by H3.Y RNAi play a role in cell cycle 
control (mitosis), as shown by a simplified GO enrichment analysis 
(Fig. 7 D), and we previously noticed a reduction in cell number 
after H3.Y and H3.X+Y knockdown, we quantitatively determined 
cell growth of U2OS cells with reduced H3.Y mRNA and protein   
levels. Therefore, we transfected U2OS cells with different variant-
specific siRNAs and quantitatively monitored cell growth for   
96 h using the xCELLigence system (Roche). Interestingly, and in 
Figure 5.  The number of cells expressing H3.X and/or H3.Y is increased 
by nutritional and proliferative stress. (A) Quantification of the percentage 
of U2OS cells positive for -H3.X/Y nuclear staining by IF analyses under 
different growth conditions. U2OS cells were stained with -H3.X/Y after   
8 d of growth under different conditions: normal, starvation, or SO. The 
percentage of cells positive for -H3.X/Y nuclear IF staining was deter-
mined (see Materials and methods for details) and plotted. A clear increase 
in the number of cells containing -H3.X/Y–positive nuclei can be seen 
after growth under SO conditions. Error bars represent SEM of three inde-
pendent biological experiments. (B) qPCR analysis of H3.X and H3.X+Y 
mRNA expression levels from U2OS cells grown under different conditions. 
From the same plates described in Fig. 5 A, cells were harvested, RNA 
was isolated, and cDNA was generated. A clear increase in H3.X+Y (dark 
gray) but not H3.X mRNA (light gray) under SO conditions can be detected, 
which is similar to the data obtained with IF analyses (Fig. 5 A). Error bars 
represent SEM of three independent biological experiments. (C) Immunoblot 
analysis of H3.X and/or H3.Y proteins isolated from U2OS cells grown 
under different conditions. From the same plates described in Fig. 5 A, 
cells were harvested, and histones were acid extracted and immunoblotted 
with -H3.X/Y antibody (top). A clear increase in a 17-kD signal can be 
seen in U2OS cells grown under different stress conditions. Recombinant 
H3.X and H3.Y proteins serve as positive controls and histones from human 
HeLa and mouse NIH3T3 cells serve as negative controls. Staining of the 
same membrane with Ponceau S solution before antibody incubation was 
performed to ensure similar loading (bottom). One representative blot from 
three independent biological experiments is shown.785 Characterization of novel histone H3.Y • Wiedemann et al.
Neuronal cell subpopulations in human 
hippocampus express novel H3  
variant proteins
Encouraged  by  our  findings  that  endogenous  H3.Y  protein 
exists in vivo and plays an essential role in cell growth and 
gene regulation, we wondered if H3.Y and/or H3.X proteins 
accordance with our global transcriptome analyses, knockdown of 
H3.Y and H3.X+Y, but not of control RNAi (luciferase), resulted 
in a significant reduction of cell growth (Fig. 7 E).
These results suggest that loss of H3.Y especially affects 
the expression of genes involved in cell cycle control, leading to 
diminished cell growth.
Figure 6.  Purification and identification of endogenous H3.Y variant protein. (A) RP-HPLC section showing histone H3 peaks (see Fig. S4 A for complete 
RP-HPLC profile). Acid-extracted histones from starved and overgrown U2OS cells (Fig. 5) were separated by RP-HPLC, and histone H3 peaks (peak I, 
H3.2+H3.3; peak II, H3.1) spanning fractions 1–31 are shown. (B) Immunoblotting analyses of RP-HPLC fractions 1–30 spanning histone H3 peaks I to II   
from different cell lines under distinct growth conditions with -H3.X/Y antibody. (i) Ponceau S staining of membrane containing histone fractions from 
starved and overgrown U2OS cells to detect H3.1, H3.2, and H3.3 proteins. Immunoblots incubated with -H3.X/Y from RP-HPLC fractions from U2OS 
cells (ii), starved and overgrown U2OS cells (iii), HEK293 cells (iv), and mouse NIH3T3 cells (v). Dotted lines indicate that intervening lanes have been 
spliced out. The two anti-H3.X/Y–positive fractions are indicated with A and B. Proteins of both fractions were independently subjected to MS/MS analyses. 
(C) List of H3-, H3.X/Y-, and H3.Y-specific peptides identified by LC-MS/MS from combined band A–corresponding fractions from U2OS cells (normal and 
SO treated; see iii). Amino acids highlighted in bold are specific for H3.X and H3.Y; a bold and underlined amino acid is found only in H3.Y.JCB • VOLUME 190 • NUMBER 5 • 2010   786
Figure 7.  Influence of H3.Y expression on global gene regulation and cell growth. (A) Specificity determination of siRNAs against novel variants. IF micros-
copy using -HA (green) and DAPI (blue) staining of HeLa cells expressing HA-H3.X and -H3.Y 4 d after RNAi treatment with indicated siRNAs. Bar, 20 µm.   
(B) qPCR analysis to verify efficient H3.X and H3.Y RNAi knockdown before global transcriptome analysis. Primer pair H3.X+Y (dark gray) specifically 
recognizes H3.X and H3.Y nucleotide sequences, whereas two other primer pairs are H3.X- (light gray) or H3.Y-specific (white). Data were normalized to 
HPRT1 and HMBS expression levels and depict fold enrichment of expression in comparison to luciferase control RNAi. Controls generated without reverse 
transcriptase were used to assess amplification threshold. Error bars represent SEM of two independent biological experiments. (C) Venn diagrams of 
genes deregulated after H3.X+Y (blue) and H3.Y (yellow) RNAi in SO-treated U2OS cells, as identified by microarray analyses of two independent experi-
ments when compared with luciferase control knockdown. Digits indicate numbers of genes significantly up- (left) or down-regulated (right) in comparison 
to luciferase control knockdown. (D) Simplified GO analysis of overlapping genes after H3.X+Y and H3.Y knockdown. Detailed GO lists are shown in   
Tables S1 and S2. Node size = total number of genes analyzed in this node (GO term/group). (E) Growth curve of U2OS cells after RNAi (red, luciferase 
control siRNA; blue, H3.X+Y siRNA; green, H3.Y siRNA). Arrows mark changes of growth medium.787 Characterization of novel histone H3.Y • Wiedemann et al.
are expressed in human tissue. Based on our qPCR results   
(Fig. 1 C), and the observation that many primate-specific 
genes are expressed in the brain and reproductive organs (Tay 
et al., 2009), we chose to analyze sections of human hippo-
campus in IF (Fig. 8 A).
Interestingly, some few cells in the region above the dentate 
gyrus (DG) of the hippocampus stained positive with -H3.X/Y 
(Fig. 8 B). We determined their cellular origin by costaining with   
antibodies against neurons ( neuronal nuclei [-NeuN] and astro-
cytes ( glial fibrillary acidic protein [-GFAP]; Fig. S5). H3.X/Y   
proteins were identified in a subpopulation of neurons outside of 
the DG (Fig. 8, B and C). This finding is in accordance with our   
observation that only few U2OS cells express large amounts of 
H3.Y. Surprisingly, -H3.X/Y staining of neurons displayed an   
enrichment in certain chromatin areas, different from that observed 
in U2OS cells (Fig. 4, C and G).
In conclusion, H3.X and/or H3.Y proteins are expressed 
in a subpopulation of neurons in the human hippocampus, high-
lighting the possibility that these novel histone variants might 
have cell type–specific functions.
Collectively, our data demonstrate that the novel histone 
variant H3.Y is expressed in human cells and specialized tis-
sues, is incorporated into chromatin, is posttranslationally mod-
ified, and impacts the regulation of many genes implicated in 
cell cycle progression.
Discussion
More than 20 yr ago, the mammalian histone H3 variants CENP-A 
(Palmer et al., 1987) and tH3 (Trostle-Weige et al., 1984) were 
found. Since then several variants of the mammalian H2A family, 
such  as  macroH2A  (Pehrson  and  Fried,  1992)  and  H2A.Bbd 
(Chadwick and Willard, 2001), have been described, but it was 
long thought that all members of the histone H3 family had been   
identified. To better understand the role of H3 variants in chromatin- 
related processes, we set out to investigate if there might be even 
more, yet unknown, H3 variants present in mammals.
H3.X and H3.Y are primate-specific 
histone genes
Using the DNA sequence of human histone H3.1 in genomic 
searches, we have now identified two novel intron-free histone 
H3 variant genes on human chromosome 5, which we named 
H3.X and H3.Y. Sequences for H3.X and H3.Y genes were, in 
addition to humans, only found in chimpanzee and macaque pri-
mate genomes; sequence information of other primate genomes   
is unfortunately not yet available. Additional Basic Local Align-
ment Search Tool (BLAST) searches in mouse, rat, and other   
genomes did not yield any positive hits, which suggests that H3.X 
and H3.Y genes are present in primates, but not in other mam-
mals or even lower eukaryotes. Both genes might be duplications 
Figure  8.  H3.X/Y  protein  expression  in   
human brain. (A) Overview IF picture of com-
mercially available human hippocampus sec-
tion stained with DAPI (DNA, gray). (B) Human 
hippocampus  sections  were  costained  with 
-H3.X/Y  (red),  -NeuN  (neuronal  marker, 
green), and DAPI (DNA, blue). The boxed sec-
tion from A is shown. Arrows indicate neuro-
nal cells with positive -H3.X/Y staining in the 
region above DG. One out of three representa-
tive stainings is shown. (C) The boxed section 
and the -H3.X/Y–positive cell marked with an 
asterisk in B are shown in higher resolution. 
Costainings  with  astrocyte  marker  antibody   
(-GFAP) are shown in Fig. S5. Bars: (A and B) 
200 µm; (C, top) 2 µm; (C, bottom) 10 µm.JCB • VOLUME 190 • NUMBER 5 • 2010   788
Our global microarray data imply that H3.Y influences the tran-
scription of several genes, either directly or indirectly. Interest-
ingly, loss of H3.Y led to more genes being down- rather than   
up-regulated, which suggests that H3.Y might be involved in tran-
scriptional activation of some genes. This is in accordance with 
our finding that H3.Y mainly localizes to euchromatic regions 
(Fig. 4 G). The majority of genes affected by H3.Y reduction are 
components of cell cycle– and chromatin structure–regulating   
pathways, leading to a significant impairment of cell growth.   
It is difficult to unequivocally assign a gene or group of genes as 
direct targets of H3.Y depletion, which would require the iden-
tification of genomic regions containing H3.Y on a global scale 
by chromatin IP followed by chip hybridization or sequencing. 
Unfortunately, IP of endogenous H3.Y protein with -H3.X/Y 
antibody turned out to be insufficient with standard protocols, 
and therefore more time and testing will be required to work 
out a functional ChIP protocol. It was surprising to us that the 
whole U2OS cell population was equally impaired in its cell 
growth after H3.Y knockdown although only few cells appeared 
to strongly express H3.Y protein, as shown by IF quantification 
(Figs. 4 C and 5 A). It is therefore possible that all U2OS cells 
express a minimal amount of H3.Y RNA and protein, which is 
beyond our detection limit, but nevertheless crucial for the cell 
to traverse through the cell cycle. To our knowledge, only one 
other histone variant showed a similar effect on the expression 
of cell cycle–related genes after RNAi depletion: knockdown of 
the linker histone variant H1.2 altered the expression of 2% of 
genes genome wide (most of them being repressed), including 
a relevant proportion of cell cycle–related genes (Sancho et al., 
2008). It is therefore not completely unlikely that H3.Y plays 
an important role in the regulation of genes involved in cell 
cycle control. It is tempting to speculate that the stress-related 
appearance of more U2OS cells expressing H3.Y is caused by 
continued cell proliferation or the prevention of cell death. One 
interesting  observation  was  that  knockdown  of  H3.Y  led  to 
stronger cell growth defects than combined H3.X+H3.Y RNAi. 
Because we repeatedly saw an increase of H3.X mRNA after 
H3.Y depletion, one speculative idea would be that H3.X and 
H3.Y are connected by some sort of regulatory feedback mech-
anism. It will be of great interest in future studies to shed light 
on the regulatory expression pathways of these novel variants, 
particularly in the context of cellular stress and their existence 
in neuronal subpopulations of the human hippocampus.
Materials and methods
Cell culture, cloning of H3.X and H3.Y expression constructs,  
and transfection
Human HeLa, HeLa Kyoto, HEK293, U2OS, mouse NIH3T3, and rat neuro-
blastoma  cells  were  grown  in  DME  medium  (PAA)  supplemented  with   
10%  FCS  (Sigma-Aldrich)  and  1%  penicillin/streptomycin  (PAA)  at 
37°C and 5% CO2. Human Raji cells were cultured in RPMI-1640 medium   
(Invitrogen) supplemented with 10% FCS (Sigma-Aldrich) and 1% penicillin/ 
streptomycin (PAA) at 37°C and 5% CO2. H3.1, H3.2, H3.3, H3.Y, and 
H3.X cDNA were cloned into pEGFP-C1 (Takara Bio Inc.) and pIRES-neo 
vector  (Takara  Bio  Inc.)  containing  an  HA  tag  (a  gift  from  H.  Dormann, 
Rockefeller University, New York, NY) to generate N-terminally tagged H3 
variants after transfection into cell lines. For simplicity, we will refer to the 
EGFP-tagged constructs as GFP-tagged throughout the text. All constructs were 
sequenced (MWG-Biotech AG) to verify cloning and amplification accuracy.   
from one ancestral gene, as their sequences are highly conserved 
even in their 5 and 3 untranslated regions, with only some differ-
ences in their putative promoter sequences. Phylogenetic analyses 
of H3.X and H3.Y coding and 3 genomic sequences revealed a 
higher sequence homology to H3.3 genes than to other H3 vari-
ants, leading to the speculation that H3.X and H3.Y might be evo-
lutionary derivatives of H3.3, although they do not contain any 
introns. To our knowledge, these are the first histone genes that 
are primate specific outside of testes and likely confer specialized 
chromatin functions unique to these higher vertebrates.
H3.X and H3.Y genes are both 
transcribed, but only H3.Y protein can  
be detected in vivo
So far we have obtained evidence that H3.X and especially H3.Y   
mRNAs are present at low but significant amounts in some   
human bone, breast, lung, and ovary tumor tissues, as well as in 
testis and certain areas of the brain. Therefore, their expression   
is not only found in transformed cell lines (U2OS) but also   
in primary human tissues. Surprisingly, we were able to verify 
only the existence of H3.Y but not H3.X protein in human cell 
lines thus far. One possibility is that alternative transcription of 
H3.X may occur. Two previous annotations of the H3.X locus 
in the NCBI database predicted several introns and different 
splice sites (Fig. S3 D); however, our primer walk experiment 
and negative qPCR data using primers specific for these splice 
forms (unpublished data) provided no evidence that alternative 
H3.X transcripts exist. Based on our results, H3.X is transcribed 
only at low levels in U2OS cells, and because no protein could 
be detected thus far, it is feasible that this particular variant is a 
pseudogene without any functional consequences. Alternatively 
and more interestingly, it is also possible that its mRNA, al-
though it is present only at low levels in some cells, may have 
unknown  regulatory  functions  and  may  even  be  influencing 
H3.Y gene expression. Future studies will hopefully shed more 
light onto a putative function of H3.X mRNA.
The number of H3.Y-expressing U2OS cells 
is increased by stress conditions
We showed that H3.Y mRNA and protein is present in some 
U2OS cells (0.1%) and that the number of cells expressing 
high levels of this novel histone variant can be increased by a 
stress response that involves nutritional starvation in combina-
tion with high cellular density. It is interesting to note that when 
calculating the amount of endogenous H3.Y mRNA per cell, we 
observe an 40-fold higher expression compared with a cell 
expressing HA-H3.Y mRNA. This suggests that once a cell re-
ceives a specific signal to start transcribing endogenous H3.Y 
or reaches a certain threshold of an unknown factor, this variant 
is expressed in extremely high amounts. It will be crucial to 
identify the physiological trigger of H3.Y expression in future 
studies to learn more about H3.Y’s cellular function.
Loss of H3.Y expression impacts 
transcriptional regulation and cell growth
To get a first glimpse on H3.Y’s potential impact on gene reg-
ulation, we knocked down H3.Y in U2OS cells using RNAi.   789 Characterization of novel histone H3.Y • Wiedemann et al.
-rabbit–Rhodamine red X and -rabbit–Cy5 (Dianova, Inc.); and -rat– 
biotin (Vector Laboratories).
IF microscopy
Adherent mammalian cells were grown on coverslips, washed, fixed in 1% 
or 3.7% formaldehyde–PBS solution, permeabilized with 0.1% or 0.5% 
Triton X-100–PBS solution, and blocked with 1% BSA in 0.1% or 0.5% Tri-
ton X-100–PBS solution. After stepwise incubation with primary and then 
secondary fluorescent antibody, cells were stained with DAPI (Invitrogen) 
and mounted with a ProLong Antifade kit (Invitrogen). Samples for 3D-SIM   
were prepared on precision cover glass No. 1.5 (thickness 0.170 ± 0.005 mm;   
Carl Roth) and embedded in Vectashield mounting medium (Vector Labora-
tories).  Chromosome  spreads  were  generated  as  described  previously 
(Hake et al., 2005). For confocal microscopy, samples were stained with 
To-Pro3 (Invitrogen) and mounted with Vectashield mounting medium (Vec-
tor Laboratories).
FRAP
For FRAP experiments, human HeLa Kyoto cells were transiently transfected 
with GFP-tagged histone H3 constructs. After 24 h, cells were seeded in 
Lab-Tek chamber slides (Thermo Fisher Scientific) and incubated for several 
hours or overnight before performing FRAP experiments. FRAP was per-
formed on a spinning disc microscope (UltraVIEW VoX; PerkinElmer) with 
an integrated FRAP PhotoKinesis accessory (PerkinElmer) assembled to an 
Axio Observer D1 stand (Carl Zeiss, Inc.). The microscope was equipped 
with a heated environmental chamber set to 37°C and CO2 perfusion set to 
5%. For photobleaching experiments, several square bleach regions with a 
size of 5 × 5 µm were positioned on selected cell nuclei within the field of 
view. Photobleaching was performed using two iterations with the acousto-
optical tunable filter of the 488-nm and the 514-nm laser line set to 100% 
transmission. To determine long-term recovery kinetics, 3D image stacks of 
8-µm height and a z distance between image planes of 1 µm were recorded 
with an initial speed of 1 frame/min for the first 10 frames, followed by   
intervals of 10 min.
Quantitative  evaluations  were  performed  with  ImageJ  (http://rsb 
.info.nih.gov/ij/). Lateral and rotational movements of the cell nucleus were 
corrected by image registration using the StackReg plug-in of ImageJ. Mean 
intensities over time were extracted from the total nuclear area (T). The 
background ROI outside of the cell was defined manually from the initial 
field of view. The mean gray values over time were measured, background 
subtracted, and normalized to the respective means of the last prebleach 
values. The resulting postbleach B values were then divided by the respec-
tive T value to correct for the superimposed gain or loss of total fluorescence 
during  postbleach  acquisition,  potentially  caused  by  newly  synthesized 
GFP-histones,  bleaching-by-acquisition,  and  flux  of  residual  fluorescence 
from above and below the recorded optical plane.
Peptide competition
-H3.X/Y antibody was incubated for 4 h at 4°C with the following peptides 
(1 µg/ml) prior to addition to the fixed cells: biotin-coupled H3.3 unmodi-
fied, aa 22–41 (Proteomics Resource Center of the Rockefeller University); 
and H3.X/Y unmodified, aa 9–20 (Peptide Specialty Laboratories GmbH).
Immunohistochemistry
Commercially available frozen sections of human hippocampus (Biochain) 
were thawed and blocked with 0.5% BSA in 0.5% Triton X-100–PBS solution. 
After stepwise incubation with primary and then secondary fluorescent   
antibodies, cells were stained with DAPI (Invitrogen) and mounted with   
Aqua-Poly/Mount (Polysciences, Inc.). To enhance -H3.X/Y signals, samples 
were incubated with a biotin-coupled -rat antibody (Vector Laboratories),   
followed by streptavidin coupled to an Alexa 555 fluorophore (Invitrogen).
Microscopes
Unless stated otherwise, samples were kept at room temperature during   
image acquisition. Stained cells were analyzed on a microscope (Axiovert 
200M) with an EC Plan-Neofluar 40×/1.3 NA oil Ph3 (differential inter-
ference  contrast  [DIC]  III)  objective  (both  from  Carl  Zeiss,  Inc.).  Images   
were  processed  with  AxioVision  software  (Carl  Zeiss,  Inc.).  Confocal   
imaging was performed with a confocal microscope (LSM 510 META; Carl 
Zeiss, Inc.) equipped with an argon-ion and two helium-ion lasers using a 
Plan-Apochromat 63×/1.4 NA oil DIC or a Plan-Neofluar 40×/1.3 NA 
oil DIC objective lens (both from Carl Zeiss, Inc.). Images were processed 
with  LSM  510  META  software  (Carl  Zeiss,  Inc.).  Images  of  metaphase 
chromosome  spreads  were  acquired  using  a  personalDV  wide-field  epi-
fluorescence microscope (Applied Precision) equipped with a 60×/1.42 
NA Plan-Apochromat oil objective lens (Olympus) and a CoolSNAP HQ
2 
Transfections  were  performed  with  FuGene  HD  (Roche)  according  to 
the  manufacturer’s  instructions.  In  brief,  cells  were  incubated  with  the 
transfection  complex  for  1  d,  after  which  selection  medium  containing   
600 µg/ml G-418 sulfate (PAA) was added. Stable cell lines were main-
tained in medium containing 400 µg/ml G-418 sulfate.
Expression of recombinant H3.X and H3.Y proteins in Escherichia coli
BL21-CodonPlus  (DE3)-RIL  bacteria  (Agilent  Technologies)  were  trans-
formed with pET-21a(+) plasmids (EMD) containing H3.X and H3.Y cDNA. 
Expression of recombinant proteins was induced by incubation with 0.1% 
IPTG (Carl Roth) overnight and controlled through SDS-PAGE analysis of 
boiled bacteria (Coomassie and immunoblot).
RNA expression analysis
Total RNA was isolated using the RNeasy mini kit (QIAGEN) according 
to the manufacturer’s instructions. Genomic DNA contaminations were re-
moved by performing an on-column DNase I digest (RNase-free DNase; 
QIAGEN). cDNA was synthesized using the ProtoScript First Strand cDNA 
Synthesis kit (New England Biolabs, Inc.), priming with random nonamers. 
qPCR analysis was performed on a LightCycler 480 (Roche) using the Light-
Cycler 480 SYBR green I mastermix (Roche). Data analysis was performed 
with the advanced relative quantification tool of the LightCycler 480 soft-
ware; results were normalized to HPRT1 and HMBS levels. H3.X and H3.Y 
primer sequences (Sigma-Aldrich) are listed in Fig. S3 C. Total RNA 
from different human tissues was commercially acquired from Applied Bio-
systems (normal lung, breast and tumor breast, and lung and ovary) and 
BioChain (tumor lung, breast, thyroid and bone, normal testis, cerebellum, 
cerebral cortex, hippocampus, thalamus, and total fetal brain).
Histone extraction and mononucleosome IP
Histones  were  acid  extracted  as  described  previously  (Shechter  et  al., 
2007). In brief, nuclei were isolated by hypotonic lysis and extracted using 
0.4 M sulfuric acid. Soluble histones were precipitated with trichloroacetic 
acid and resuspended in water.
Mononucleosomes for IP experiments were generated as described 
previously (Wysocka et al., 2001), with the following changes: For cell 
lysis, 0.1% NP-40 was used instead of Triton X-100. All centrifugation 
steps before MNase treatment were performed at 3,200 g. Mononucleo-
somes were generated by digestion of chromatin with 0.25 U MNase 
(Sigma-Aldrich) for 15 min in buffer A (10 mM Hepes, pH 7.9, 10 mM 
KCl, 1.5 mM MgCl2, 0.34 M sucrose, 10% glycerol [vol/vol], 1 mM DTT, 
and protease inhibitor cocktail [Roche] plus 1 mM CaCl2) and stopped 
by the addition of EGTA (final concentration of 2 mM). Centrifugation 
was performed at 20,000 g for 20 min. Supernatants of four MNase 
digests were combined, and salt concentration was adjusted to 150 mM 
KCl. Magnetic beads (Invitrogen) were washed four times with buffer C 
(20 mM Hepes/KOH, pH 7.9, 20% [vol/vol] glycerol, 0.2 mM EDTA, 
0.2% [vol/vol] Triton X-100, 300 mM KCl, and protease inhibitor cocktail 
[Roche]). One part was evaluated for DNA size and quality using DNA 
1000 reagents (Agilent Technologies) with the 2100 Bioanalyzer (Agilent 
Technologies), another part was analyzed by immunoblotting using the 
Odyssey infrared imaging system (LI-COR Biosciences) and evaluated with 
Odyssey Software Version 2.1 (LI-COR Biosciences), and the last part was 
analyzed by silver staining.
Antibodies
To generate an antibody against H3.X and H3.Y (-H3.X/Y), a peptide 
spanning amino acids KATAWQAPRKLP of histone H3.X and H3.Y was 
synthesized (Peptide Specialty Laboratories GmbH) and coupled to BSA 
and  ovalbumin,  respectively.  Rats  were  immunized  subcutaneously  and   
intraperitoneally with a mixture of 50 µg peptide-ovalbumin, 5 nmol CPG 
oligonucleotide (TIB MOLBIOL GmbH), 500 µl PBS, and 500 µl of incom-
plete Freund’s adjuvant. A boost without adjuvant was given 6 wk after the 
primary injection. Fusion was performed using standard procedures (Köhler 
and Milstein, 1975). Supernatants were tested by differential ELISA with the 
histone peptide coupled to BSA and an irrelevant peptide coupled to the 
same carrier. Monoclonal antibodies that reacted specifically with the pep-
tide were further analyzed in immunoblot and IF studies. -H3.X/Y clone 
8H6-2111 of rat IgG2a subclass was deployed in this study.
The following primary antibodies were used in this study: -HA (clone 
12CA5; Roche), -H3S10ph (Millipore), -H3 (C terminus; Abcam), -NeuN 
(Millipore), and -GFAP (Dako).
The  following  secondary  antibodies  were  used:  -rat  HRP  and 
-rabbit  HRP  (GE  Healthcare);  -mouse–IRDye700DX  and  -rabbit–
IRDye800DX (Rockland Immunochemicals, Inc.); -rat–Alexa Fluor 488, 
-mouse–Alexa Fluor 488, and streptavidin-Alexa 555 (Invitrogen); and JCB • VOLUME 190 • NUMBER 5 • 2010   790
monitored over the next 4 d. To eliminate side effects caused by the lack of 
nutrients or the accumulation of waste products, growth medium was ex-
changed every day.
Microarray hybridization
Total RNA preparations were further purified with the RNeasy MinElute 
Cleanup kit (QIAGEN). 100 ng of RNA were used as starting material 
for all target preparations. RNA amplification, labeling, and hybridization 
to Human Gene 1.0 ST Arrays (Affymetrix) were performed according to   
the Human Gene 1.0 ST Array kit protocol (Affymetrix). The raw micro-
array data were processed in R/Bioconductor (http://www.bioconductor 
.org/) as follows: gene-based expression values were calculated using the 
robust multichip average (RMA) method provided by the oligo package. 
Genes that had a log2 expression value of at least 4 in at least one of the   
treatment conditions were kept for downstream analyses. Differential expres-
sion estimation was based on a moderated t statistic (limma package) with 
subsequent calculation of the local false discovery rate (lfdr; locfdr pack-
age). Genes were classified as responders by an lfdr cutoff of 0.2. GO   
enrichment analysis was performed using a hypergeometric distribution test and 
subsequent Bonferroni correction as supplied by the GOHyperGALL script 
(http://faculty.ucr.edu/~tgirke/Documents/R_BioCond/My_R_Scripts/ 
GOHyperGAll.txt).  We  reduced  term  redundancy  by  applying  the   
GOHyperGAll_Simplify function with a P-value cutoff of 0.001.
Online supplemental material
Fig. S1 shows H3.X and H3.Y alignments, evolutionary origin, and ex-
pression level determination. Fig. S2 shows analysis of H3.X- and H3.Y- 
containing nucleosomes, and -H3.X/Y antibody specificity determina-
tion. Fig. S3 shows evaluation of human H3.X sequences and inducible 
endogenous H3.X and H3.Y gene expression. Fig. S4 shows purifica-
tion and mass spectrometrical identification of endogenous H3.Y protein. 
Fig. S5 shows H3.X/Y expression in the human hippocampus. Table S1 
shows a GO list with shared up-regulated genes after H3.Y knockdown. 
Table S2 shows a GO list with shared down-regulated genes after H3.Y 
knockdown. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.201002043/DC1.
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charge-coupled device (CCD) camera (Photometrics). Typically, stacks with a   
z distance of 200 nm were recorded and then subjected to a constrained 
iterative deconvolution (enhanced ratio, 10 cycles, medium noise filtering) 
using the SoftWoRx 3.7 imaging software package (Applied Precision). For 
a description about the microscopic setup used for FRAP, see the descrip-
tion for in the FRAP section. Imaging with 3D-SIM was performed with an 
DeltaVision  OMX  v3  prototype  (Applied  Precision)  equipped  with  high-
power diode lasers with wavelengths of 405, 488 and 592.2 nm; a 100×/ 
1.4 NA Plan-Apochromat oil objective lens (Olympus); and Cascade II:512 
EM CCD cameras (Photometrics). Laser light is directed through a movable 
optical grating to generate a fine-striped illumination pattern on the sample 
plane. Image stacks with 15 images per plane (five phases, three angles) 
and a z distance of 125 nm were acquired and subjected to a compu-
tational reconstruction to obtain a high-resolution 3D dataset with a two-
fold enhanced optical resolution in all three special directions compared   
with conventional light microscopy (Gustafsson et al., 2008; Schermelleh   
et al., 2008). Immunohistochemistry samples were analyzed using a con-
focal LSM 710 microscope (Carl Zeiss, Inc.) equipped with three argon, one   
diode-pumped solid-state, one helium, and one diode laser. Images were   
acquired using an EC Plan-Neofluar 10×/0.3 NA M27, an LD C-Apochromat 
40×/1.1 W Korr M27 (water), or a LCI Plan-Neofluar 63×/1.3-mm Korr 
Ph3 M27 (water) objective lens (all from Carl Zeiss, Inc.), and Image pro-
cessing was performed with ZEN 2009 (Carl Zeiss, Inc.) software.
For downstream image processing of all microscope images, Photo-
shop (Adobe) software packages were used.
In silico modeling
To generate homology models from protein sequences, we used the I-TASSER 
server (Zhang, 2008). I-TASSER combines threading, assembly, and refine-
ment to generate 3D models. For sequences of both H3.X and H3.Y, the 
server automatically selected as a template the chain A (histone H3.2), PDB   
accession no. 1kx5. This structure was obtained using X. laevis histones   
assembled into nucleosomes with 147 bp of DNA from Homo sapiens 
(Davey et al., 2002). The model for H3.X had a C score of 0.07, and the 
model for H3.Y had a C score of 1.50. In both cases, the second-best model 
had a considerably lower C score. Datasets of the models were down-
loaded and visualized by means of the Swiss-PdbViewer (Guex and Peitsch, 
1997) and PyMOL (DeLano Scientific LLC; http://www.pymol.org).
RP-HPLC and MS/MS
Histones from U2OS, HEK293, and NIH3T3 cells were separated by   
RP-HPLC on a C4 column (250 × 4.6-mm Jupiter, 10 µm, 300 Å; Phenomenex) 
using a linear gradient of 35–53% solvent B (solvent A, 0.1% trifluoroacetic 
acid; solvent B, 99.92% acetonitrile and 0.08% trifluoroacetic acid) over 
30 min at 1.0 ml/min on a Biotech Ettan microLC (GE Healthcare). The 
H3-containing fractions were dried under vacuum and stored at 20°C. 
For mass spectrometry analysis, RP-HPLC fractions containing histones were 
resolved in 0.1 M ammonium bicarbonate and digested. Proteolytic diges-
tions were performed overnight at 37°C with sequencing grade trypsin 
(Promega). In this case, histones were chemically modified beforehand by 
treatment with propionic anhydride (Merck) to convert free amino groups of 
lysine residues to propionic amides. After digestion, samples were directly 
loaded onto a nano electrospray ionization (ESI) LC-MS/MS for protein 
identification. Each sample was first separated on a C18 reversed phase 
column via a linear acetonitrile (Sigma-Aldrich) gradient (UltiMate 3000 
system [Dionex] and an LC Packings column; 75 µm inner diameter × 15 cm, 
packed with C18 PepMap, 3 µm, 100 Å) before MS and MS/MS spectra 
were recorded on an Orbitrap mass spectrometer (Thermo Fisher Scientific). 
The resulting data were analyzed via the Mascot Software (Matrix Science) 
using a home-made database that contains the diverse H3 sequences. Frag-
ment spectra were also interpreted manually.
RNAi and growth curve
siRNAs were designed using siDESIGN Center (http://www.dharmacon 
.com/designcenter/designcenterpage.aspx; Thermo Fisher Scientific) and 
synthesized (MWG-Biotech AG). siRNAs have been prevalidated to con-
firm their targeting specificity to H3.Y or H3.X+H3.Y and to reduce the 
chance of off-target effects by BLAST searches (NCBI). The following double-
stranded siRNAs, which had differences of at least three nucleotides from 
other targets, were used. Luciferase, 5-CUUACGCUGAGUACUUCGA-3; 
H3.Y, 5-CCGCAGAGAGGGUCCUUAA-3; H3.X+Y, 5-GCGGGAAAU-
CAGAAAGUAC-3. Cells were transfected twice with siRNAs using oligo-
fectamine (Invitrogen) according to the manufacturer’s instructions. 4 d after 
transfection, cells were used for various assays. Determination of cell growth 
after RNAi was performed using xCELLigence system (Roche). Cells were 
seeded in E plates 1 d after the second siRNA transfection. Cell growth was 791 Characterization of novel histone H3.Y • Wiedemann et al.
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